NK cells restrain cytotoxic CD8+ T cells in the submandibular gland via PD-1–PD-L1

IF 17.6 1区 医学 Q1 IMMUNOLOGY
Samantha M. Borys, Shanelle P. Reilly, Ian Magill, David Zemmour, Laurent Brossay
{"title":"NK cells restrain cytotoxic CD8+ T cells in the submandibular gland via PD-1–PD-L1","authors":"Samantha M. Borys,&nbsp;Shanelle P. Reilly,&nbsp;Ian Magill,&nbsp;David Zemmour,&nbsp;Laurent Brossay","doi":"10.1126/sciimmunol.adl2967","DOIUrl":null,"url":null,"abstract":"<div >The increasing use of anti–programmed cell death 1 (PD-1) immune checkpoint blockade has led to the emergence of immune-related adverse events (irAEs), including dysfunction of the submandibular gland (SMG). In this study, we investigated the immunoregulatory mechanism contributing to the susceptibility of the SMG to irAEs. We found that the SMGs of PD-1–deficient mice and anti–programmed cell death ligand 1 (PD-L1)–treated mice harbor an expanded population of CD8<sup>+</sup> T cells. We demonstrate that natural killer (NK) cells expressing PD-L1 tightly regulate CD8<sup>+</sup> T cells in the SMG. When this immunoregulation is disrupted, CD8<sup>+</sup> T cells clonally expand and acquire a unique transcriptional profile consistent with T cell receptor (TCR) activation. These clonally expanded cells phenotypically overlapped with cytotoxic GzmK<sup>+</sup> CD8<sup>+</sup> T autoimmune cells identified in patients with primary Sjögren’s syndrome. Understanding how NK cells modulate CD8<sup>+</sup> T cell activity in the SMG opens new avenues for preventing irAEs in patients undergoing checkpoint blockade therapies.</div>","PeriodicalId":21734,"journal":{"name":"Science Immunology","volume":"9 102","pages":""},"PeriodicalIF":17.6000,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Science Immunology","FirstCategoryId":"3","ListUrlMain":"https://www.science.org/doi/10.1126/sciimmunol.adl2967","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

The increasing use of anti–programmed cell death 1 (PD-1) immune checkpoint blockade has led to the emergence of immune-related adverse events (irAEs), including dysfunction of the submandibular gland (SMG). In this study, we investigated the immunoregulatory mechanism contributing to the susceptibility of the SMG to irAEs. We found that the SMGs of PD-1–deficient mice and anti–programmed cell death ligand 1 (PD-L1)–treated mice harbor an expanded population of CD8+ T cells. We demonstrate that natural killer (NK) cells expressing PD-L1 tightly regulate CD8+ T cells in the SMG. When this immunoregulation is disrupted, CD8+ T cells clonally expand and acquire a unique transcriptional profile consistent with T cell receptor (TCR) activation. These clonally expanded cells phenotypically overlapped with cytotoxic GzmK+ CD8+ T autoimmune cells identified in patients with primary Sjögren’s syndrome. Understanding how NK cells modulate CD8+ T cell activity in the SMG opens new avenues for preventing irAEs in patients undergoing checkpoint blockade therapies.
NK细胞通过PD-1-PD-L1抑制颌下腺细胞毒性CD8 + T细胞
越来越多地使用抗程序性细胞死亡1 (PD-1)免疫检查点阻断导致免疫相关不良事件(irAEs)的出现,包括颌下腺(SMG)功能障碍。在这项研究中,我们研究了影响SMG对irAEs易感性的免疫调节机制。我们发现pd -1缺陷小鼠和抗程序性细胞死亡配体1 (PD-L1)处理小鼠的smg中含有更多的CD8 + T细胞。我们证明了表达PD-L1的自然杀伤细胞(NK)在SMG中紧密调节CD8 + T细胞。当这种免疫调节被破坏时,CD8 + T细胞克隆扩增并获得与T细胞受体(TCR)激活一致的独特转录谱。这些克隆扩增的细胞在表型上与原发性Sjögren综合征患者中发现的细胞毒性GzmK + CD8 + T自身免疫细胞重叠。了解NK细胞如何调节SMG中CD8 + T细胞的活性,为接受检查点阻断治疗的患者预防irae开辟了新的途径。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Science Immunology
Science Immunology Immunology and Microbiology-Immunology
CiteScore
32.90
自引率
2.00%
发文量
183
期刊介绍: Science Immunology is a peer-reviewed journal that publishes original research articles in the field of immunology. The journal encourages the submission of research findings from all areas of immunology, including studies on innate and adaptive immunity, immune cell development and differentiation, immunogenomics, systems immunology, structural immunology, antigen presentation, immunometabolism, and mucosal immunology. Additionally, the journal covers research on immune contributions to health and disease, such as host defense, inflammation, cancer immunology, autoimmunity, allergy, transplantation, and immunodeficiency. Science Immunology maintains the same high-quality standard as other journals in the Science family and aims to facilitate understanding of the immune system by showcasing innovative advances in immunology research from all organisms and model systems, including humans.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信